14. Heart Failure and Cardiomyopathies: Therapy 1027-07

1027-07 - DAPAGLIFLOZIN IMPROVES OUTCOMES IRRESPECTIVE OF NT-PROBNP CONCENTRATION IN PATIENTS WITH HFREF: AN ANALYSIS OF THE DAPA-HF TRIAL

Session
1027 - The Buzz in SGLT2 Inhibitors and Heart Failure
Speakers
Pathway
14. Heart Failure and Cardiomyopathies: Therapy
Presentation Number
1027-07
Presentation Rating
 |